Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.1213 | 90 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.12451 | 89 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.20644 | 90 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.138 | 89 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.17222 | 89 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.30207 | 92 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.51018 | 92 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.21086 | 90 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.34633 | 91 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.18608 | 90 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.17694 | 90 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.12683 | 89 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.37184 | 91 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.1926 | 90 |